Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement

Joerg Herrmann(Mayo Clinic), Peter Valent(Medical University of Vienna), Giuseppe Curigliano(European Institute of Oncology), Teresa López‐Fernández(Hospital Universitario La Paz), Ninian N. Lang(British Heart Foundation), Joshua D. Mitchell(Twitter (United States)), Daniela Cardinale(European Institute of Oncology), Kathryn J. Ruddy(Mayo Clinic in Arizona), Ana Barac(Inova Fairfax Hospital), Kerry L. Reynolds(Massachusetts General Hospital), Anne Blaes(University of Minnesota), Iskra Pusic(Washington University in St. Louis), Saro H. Armenian(City of Hope), Daniel J. Lenihan(Saint Francis Medical Center), Susan Dent(Government of the United States of America), Sarju Ganatra(Lahey Hospital and Medical Center), Michael G. Fradley(University of South Florida), Joseph R. Carver(Hospital of the University of Pennsylvania), Alexander R. Lyon(Royal Brompton Hospital), Charles Porter(University of Kansas Medical Center), Paaladinesh Thavendiranathan(University of Toronto), Jennifer E. Liu(Memorial Sloan Kettering Cancer Center), Bonnie Ky(Virginia Commonwealth University), Tomas G. Neilan(Albert Einstein College of Medicine), Giorgio Minotti(Università Campus Bio-Medico), Rupal O’Quinn(University of Pennsylvania), Anju Nohria(Brigham and Women's Hospital)
European Heart Journal
September 10, 2021
Cited by 589


Related Papers